Neoplasms, Connective Tissue: Clinical Trials

668 trials for Neoplasms, Connective Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

329 completed, 91 recruiting, 78 terminated, 64 unknown. 668 Phase 2, 136 Phase 1, 21 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2668Completed 329, Recruiting 91, Terminated 78, Unknown 64, Active not recruiting 62, Not yet recruiting 24, Withdrawn 14, Suspended 4, Enrolling by invitation 2
Phase 1136Completed 53, Recruiting 28, Terminated 18, Active not recruiting 14, Unknown 13, Not yet recruiting 6, Withdrawn 2, Enrolling by invitation 1, Suspended 1
Phase 321Completed 7, Unknown 6, Terminated 4, Recruiting 2, Active not recruiting 1, Suspended 1

Follow Neoplasms, Connective Tissue: new trials by email Literature Review of Neoplasms, Connective Tissue trials Research Report on Neoplasms, Connective Tissue

Trials (filtered) newest first · largest first

All 668 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
Pimicotinib, Tumor resection surgery - Tenosynovial Giant Cell Tumor, Diffuse
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine842027-10-012026-07-16
Combination Immunotherapy Targeting Sarcomas
Multiple sarcoma-specific CAR-T cells and sarcoma vaccines - Sarcoma, Osteoid Sarcoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute202027-07-012026-11-02
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Sarcoma-specific CAR-T cells - Sarcoma, Osteoid Sarcoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute202027-06-012026-10-30
A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat
Archive Sample Retrieval, Biospecimen Collection, pH Low Insertion Peptide-exatecan Conjugate CBX-12 - Recurrent Childhood Ewing Sarcoma, Recurrent Childhood Malignant Solid Neoplasm
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group792027-05-072026-09-22
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma
DT-7012, Doxorubicin - Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS)
Phase 2Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris802027-02-012026-09-15
RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT
LX-101 - Ewing Sarcoma
Phase 2Not yet recruitingM.D. Anderson Cancer Center1202027-02-012026-08-24
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD252027-01-012026-10-28
Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers
Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Biopsy Procedure, Biospecimen Collection - Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma
Phase 2Not yet recruitingNational Cancer Institute (NCI)422026-11-232026-09-25
A Study of DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT
DCC-3014 - Tenosynovial Giant Cell Tumor
Phase 2Not yet recruitingOno Pharmaceutical Co., Ltd.182026-10-312026-09-22
The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma
High-dose Methotrexate - Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Phase 2RecruitingWake Forest University Health Sciences462026-10-312026-11-04
NAC-REPAIR for Post-surgical Pain
NAC, NAC 0mg/day (Placebo) - Carpal Tunnel Surgery, Trigger Finger Disorder
Phase 2Not yet recruitingUniversity of Arizona802026-10-152026-07-17
A Legacy Study in Participants With Gastrointestinal Stromal Tumors (GIST)
Velzatinib - Gastrointestinal Neoplasms
Phase 2Not yet recruitingGlaxoSmithKline722026-10-132026-09-28
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
Lifileucel - Sarcoma, Soft Tissue Sarcoma (STS)
Phase 2RecruitingIovance Biotherapeutics, Inc.802026-10-022026-10-09
Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.
Dinutuximab beta, Sirolimus and Irinotecan - Osteosarcomas, Bone Cancer
Phase 1 / Phase 2Not yet recruitingUniversity Hospital, Strasbourg, France892026-10-012026-10-01
A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue Sarcoma
SOT106 - Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS)
Phase 1 / Phase 2Not yet recruitingSOTIO Biotech a.s.702026-09-302026-09-03
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy - Advanced Cancer, Stage IV Solid Tumor Cancer
Phase 2Not yet recruitingUniversity Health Network, Toronto462026-09-142026-10-15
SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma
Toripalimab, Liposomal doxorubicin, Stereotactic body radiotherapy (SBRT) - Undifferentiated Pleomorphic Sarcoma (UPS)
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital392026-09-012026-09-14
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
Cyclophosphamide, Fludarabine, Mesna - Pediatric Osteosarcoma
Phase 2RecruitingSt. Jude Children's Research Hospital412026-08-212026-11-03
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
Velzatinib - Gastrointestinal Neoplasms
Phase 2RecruitingGlaxoSmithKline242026-08-172026-10-01

Showing 20 of 668. Sign in to see all of them.

Narrower conditions

Osteosarcoma (210)  ·  Sarcoma (205)  ·  Gastrointestinal Stromal Tumors (134)  ·  Sarcoma, Ewing (111)  ·  Rhabdomyosarcoma (88)  ·  Sarcoma, Synovial (66)  ·  Neuroblastoma (62)  ·  Neurofibrosarcoma (57)  ·  Leiomyosarcoma (55)  ·  Histiocytoma, Malignant Fibrous (54)  ·  Liposarcoma (49)  ·  Neuroectodermal Tumors, Primitive, Peripheral (46)  ·  Chondrosarcoma (42)  ·  Fibrosarcoma (39)  ·  Ovarian Neoplasms (37)

Broader conditions

Neoplasms by Histologic Type (667)  ·  Neoplasms, Connective and Soft Tissue (664)  ·  Neoplasms (638)  ·  Neoplasms, Bone Tissue (281)  ·  Sarcoma (223)  ·  Neoplasms, Fibrous Tissue (181)  ·  Neoplasms by Site (177)  ·  Neoplasms, Nerve Tissue (161)  ·  Neoplasms, Glandular and Epithelial (158)  ·  Digestive System Diseases (155)  ·  Digestive System Neoplasms (152)  ·  Gastrointestinal Diseases (144)  ·  Gastrointestinal Neoplasms (136)  ·  Neoplasms, Muscle Tissue (135)

Interventions

Imatinib Mesylate (44)  ·  Doxorubicin (36)  ·  Ifosfamide (30)  ·  Cyclophosphamide (29)  ·  Cisplatin (21)  ·  Gemcitabine (20)  ·  Radiotherapy (20)  ·  Temozolomide (20)  ·  Etoposide (19)  ·  Specimen Handling (18)  ·  Magnetic Resonance Spectroscopy (17)  ·  Methotrexate (17)  ·  Vincristine (17)  ·  Filgrastim (16)  ·  Sirolimus (16)

Sponsors

National Cancer Institute (NCI) (81)  ·  M.D. Anderson Cancer Center (28)  ·  Memorial Sloan Kettering Cancer Center (25)  ·  Novartis Pharmaceuticals (19)  ·  Children's Oncology Group (15)  ·  Asan Medical Center (14)  ·  European Organisation for Research and Treatment of Cancer - EORTC (14)  ·  Sarcoma Alliance for Research through Collaboration (14)  ·  Peking University People's Hospital (11)  ·  Italian Sarcoma Group (9)  ·  St. Jude Children's Research Hospital (9)  ·  Eli Lilly and Company (8)  ·  Centre Leon Berard (7)  ·  Dana-Farber Cancer Institute (7)  ·  Grupo Espanol de Investigacion en Sarcomas (7)

Countries

United States (393)  ·  France (85)  ·  China (63)  ·  Canada (62)  ·  Italy (62)  ·  Germany (56)  ·  Spain (55)  ·  United Kingdom (53)  ·  Netherlands (49)  ·  Australia (46)  ·  South Korea (35)  ·  Belgium (34)  ·  Poland (32)  ·  Puerto Rico (22)  ·  Japan (19)

Top investigators

Silvia Stacchiotti, MD (6)  ·  AeRang Kim, MD, PhD (5)  ·  Hedy Kindler (4)  ·  Margaret von Mehren, MD (4)  ·  Richard Gorlick, MD (4)  ·  Yoon-Koo Kang, MD, PhD (4)  ·  Antonio Casado (3)  ·  Brian H. Kushner, MD (3)  ·  Claudia Valverde (3)

Results publications

PMID 31401903, PMID 19451433, PMID 22682017, PMID 27355533, PMID 30477937, PMID 31013172, PMID 32192573, PMID 32827353, PMID 34416158, PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15084390, PMID 15177491, PMID 15592836, PMID 15659504, PMID 16314647, PMID 16435380, PMID 16528479, PMID 16532433, PMID 16775235, PMID 17095209, PMID 17109446, PMID 17290057, PMID 17336054, PMID 17715389, PMID 18006112, PMID 18448563, PMID 18676758, PMID 18942073, PMID 19088049, PMID 19338063, PMID 19451429, PMID 20226028, PMID 20338746, PMID 20471824, PMID 20525721, PMID 20576718, PMID 20622000, PMID 20715156, PMID 20837357, PMID 20838998, PMID 20881264, PMID 20932656, PMID 20943374, PMID 21098399, PMID 21108325, PMID 21387287, PMID 21456006

NIH funding

U10CA180886 (22), U10CA098543 (14), U10CA032102 (10), 2023 (7), P30CA008748 (7), U10CA031946 (7), U10CA180821 (5), 2009 (4), 2015 (4), 2017 (4), P30CA014599 (4), P30CA033572 (4), UM1CA228823 (4), 2014 (3), 2018 (3)